CDK4 and cancer: CDK4/6 inhibitors specifically accelerate the induction of cellular senescence by inhibiting CDK4/6-induced phosphorylation of RB, subsequently activate immunosurveillance by SASP, and effectively clear senescent cancer cells including HCC cells (16, 28).